Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 4:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 6,915 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
Interventions: transcranial electrical stimulation; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Leukemia, Lymphoma
Interventions: Filgrastim, Rituximab, Cyclophosphamide, Cytarabine, Methotrexate, Prednisone, Hydrocortisone, Vincristine, Leucovorin; Biological · Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 30 Years to 120 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 2
States / cities: Baltimore, Maryland • Philadelphia, Pennsylvania

Conditions: Spinal Cord Injuries, Tetraplegia, Quadriplegia
Interventions: Using the Neuroport cortical recording array to determine the desired grasp pattern for a functional electrical stimulation (FES) system; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Treatment Resistant Depression
Interventions: Medtronic Activa PC+S System; Device
Lead sponsor: Emory University; Other
Eligibility: 25 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2029
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Effect of tDCS on Memory in Older and Younger Adults
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 271 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke
Interventions: Repetitive Peripheral Magnetic Stimulation (rPMS), Sham Priming; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Pain, Pain Perception, Healthy Adult Participants
Interventions: Active transcutaneous vagus nerve stimulation, Sham transcutaneous vagus nerve stimulation, Cold pressor test; Device · Other
Lead sponsor: David A. Purger; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pain, Neuropathic, Complex Regional Pain Syndromes, Phantom Limb Pain, Spinal Cord Injuries
Interventions: transcranial direct current stimulation; Device
Lead sponsor: Susan McDowell; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Root Canal Therapy
Interventions: Collagen-hydroxyapatite scaffold (Syn-Oss), Collagen Scaffold (Colla-Plug); Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 12 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Chronic Pain, Hemiplegic Shoulder Pain
Interventions: StimRouter Neuromodulation System; Device
Lead sponsor: Bioness Inc; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Miami, Florida • Salt Lake City, Utah

Conditions: Adiposity
Interventions: Exercise; Other
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Retinitis Pigmentosa
Interventions: Argus II; Device
Lead sponsor: University of California, Santa Barbara; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Santa Barbara, California • Baltimore, Maryland • Ann Arbor, Michigan

Conditions: Memory Performance, Hippocampal Network Activity
Interventions: Transcranial magnetic stimulation (TMS); Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Plaque Psoriasis.
Interventions: Gadolinium, Efficacy of Enbrel subcutaneously at Week 12, Efficacy of Enbrel subcutaneously at Week 24, Efficacy of Enbrel subcutaneously at Week 36, Efficacy of Enbrel subdermally at Week 12, Efficacy of Enbrel subdermally at Week 24, Efficacy of Enbrel subdermally at Week 36, PASI 75 n(%) subcutaneously at Week 12, PASI 75 n(%) subcutaneously at Week 24, PASI 75 n(%) subcutaneously at Week 36, PASI 75 n(%) subdermally at Week 12, PASI 75 n(%) subdermally at Week 24, PASI 75 n(%) subdermally at Week 36, Adverse Reactions of Enbrel subcutaneously, Adverse Reactions of Enbrel subdermally at Week 36; Drug
Lead sponsor: ASIS Corporation; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Westminster, California

Conditions: Spinal Cord Injury
Interventions: EAW+SCES (exoskelton and spinal cord epidural stimulation), EAW+TS (exoskelton and transspinal stimulation); Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Tinnitus
Interventions: Burst-SCS/sham SCS, Sham SCS/Burst-SCS; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Parkinson Disease
Interventions: e-Tapper TT-R1; Device
Lead sponsor: Boston University; Other
Eligibility: 50 Years to 75 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Infections, Cytopenias
Interventions: Sargramostim; Drug
Lead sponsor: Sandoz; Industry
Eligibility: 18 Years to 50 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 2
States / cities: Los Angeles, California • Boston, Massachusetts

Conditions: Beta Rhythm, Tactile Perception
Interventions: Online Active SI-Hand TMS, Online Sham SI-Hand TMS, Online Active Control TMS; Device
Lead sponsor: Brown University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Breast Cancer
Interventions: filgrastim, cyclosporine, peripheral blood stem cell transplantation, indium In 111 monoclonal antibody m170, yttrium Y 90 monoclonal antibody m170; Biological · Drug · Procedure + 1 more
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1996
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Spinal Cord Injury
Interventions: TESS, Training, Motor Task, sham-TESS; Device · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois • Hines, Illinois

Conditions: Endometriosis, Infertility
Interventions: Leuprolide acetate in depot suspension, No intervention; Drug · Other
Lead sponsor: Colorado Center for Reproductive Medicine; Other
Eligibility: 21 Years to 42 Years · Female only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Lone Tree, Colorado

Conditions: Episodic Memory
Interventions: Brain stimulation; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression, Anxiety, Major Depressive Disorder
Interventions: Transcranial magnetic stimulation; Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Feasibility Electrical Stimulation Study for Visual Hallucinations

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia

Restoring High Dimensional Hand Function to Persons With Chronic High Tetraplegia

Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S

Effect of Noninvasive Electrical Brain Stimulation on Memory at Different Times of Day in Younger and Older Adults

The Effect of rPMS on Motor Skill Performance in Persons With a Stroke.

Effects of Transcutaneous Vagus Nerve Stimulation on Pain and Brain Activity in Healthy Adults

Modulating Neuropathic Pain With Transcranial Direct Current Stimulation

Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue

StimRouter™ for Pain Management in Post-stroke Shoulder Pain

Myokine Identification Following Acute Exercise

The Perceptual Experience of Argus II Users

Intracranial EEG to Test How Noninvasive Stimulation Affects Hippocampal-dependent Memory

ASIS for Enbrel in Plaque Psoriasis

Neuromodulation Techniques After SCI

Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts

Bio Electro Stimulation Therapy for Parkinson's Disease

An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Beta Events and Sensory Perception

Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer

Spinal Cord Stimulation for Functional Recovery in Humans With Tetraplegia

Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF

In-depth Investigation of Brain Network Interactions

Symptom-specific TMS Targets for Depression and Anxiety